Lymphoma Clinical Trial
Official title:
@neWorld: A Virtual Community For Kids With Cancer
RATIONALE: Using an Internet Web site that enables children with cancer to interact online
with classmates, participate in classroom activities, get easy-to-read medical information,
and chat with family members, medical staff, and other children with cancer may help
children cope with isolation, fear, and decreased self-esteem.
PURPOSE: This phase I/II trial is studying the effectiveness of an Internet Web site in
providing social support and education to children who are undergoing treatment for cancer.
OBJECTIVES:
- Develop an Internet-based application that allows pediatric patients with cancer to
enter a virtual community with the following capabilities:
- Interact with classmates and participate in classroom activities via e-mail, chat
groups, online field trips, art studio, music room, and game room
- Identify and interact with a community of peers with similar medical conditions
- Access a dictionary to get medical information in understandable terms
- Interact with the medical community online
- Interact with family members online
- Determine the acceptability of this program among groups of these patients and their
classmates, teachers, family members, and healthcare providers using focus groups.
- Determine the effect of this program on self-esteem, coping behaviors, perceived social
support, cancer-relevant medical knowledge, and feelings of control over health destiny
in these patients.
- Determine the effect of this program on the performance of these patients in school.
- Determine the effect of this program in alleviating psychological distress in these
patients.
OUTLINE: This is a multicenter study.
- Phase I: Students, family members, teachers, and health providers participate in focus
groups to provide system design and implementation input and to assess overall
acceptability of a prototype Internet-based application for pediatric cancer patients.
- Phase II: Patients are assigned to 1 of 2 groups, based on participating center.
- Group 1: Patients have access to and utilize the Internet-based application
@neWorld.
- Group 2: Patients do not have access to or utilize @neWorld. In both groups,
patients complete questionnaires measuring psychological distress, quality of
life, self-esteem, coping behaviors, perceived academic and social competence,
perceived social support, cancer-relevant medical knowledge, feelings of control
over health destiny, utilization of psychological services, and performance in
school at baseline and 3 and 6 months.
PROJECTED ACCRUAL: A total of 94 patients (44 for group 1 and 50 for group 2) will be
accrued for this study.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05540340 -
A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant
|
Phase 1 | |
| Completed |
NCT01947140 -
Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies
|
Phase 1/Phase 2 | |
| Completed |
NCT00001512 -
Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines
|
Phase 1 | |
| Recruiting |
NCT05618041 -
The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies
|
N/A | |
| Completed |
NCT01410630 -
FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma
|
||
| Active, not recruiting |
NCT04270266 -
Mind-Body Medicine for the Improvement of Quality of Life in Adolescents and Young Adults Coping With Lymphoma
|
N/A | |
| Terminated |
NCT00801931 -
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
|
Phase 1/Phase 2 | |
| Completed |
NCT01949883 -
A Phase 1 Study Evaluating CPI-0610 in Patients With Progressive Lymphoma
|
Phase 1 | |
| Completed |
NCT01682226 -
Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies
|
Phase 2 | |
| Completed |
NCT00003270 -
Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
|
Phase 2 | |
| Recruiting |
NCT05019976 -
Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma
|
N/A | |
| Recruiting |
NCT04904588 -
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide
|
Phase 2 | |
| Completed |
NCT04434937 -
Open-Label Study of Parsaclisib, in Japanese Participants With Relapsed or Refractory Follicular Lymphoma (CITADEL-213)
|
Phase 2 | |
| Completed |
NCT01855750 -
A Study of the Bruton's Tyrosine Kinase Inhibitor, PCI-32765 (Ibrutinib), in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma
|
Phase 3 | |
| Terminated |
NCT00788125 -
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
|
Phase 1/Phase 2 | |
| Terminated |
NCT00775268 -
18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT04188678 -
Resiliency in Older Adults Undergoing Bone Marrow Transplant
|
N/A | |
| Terminated |
NCT00014560 -
Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
|
Phase 1 | |
| Recruiting |
NCT04977024 -
SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT03936465 -
Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer
|
Phase 1 |